NCT05188456 is a clinical trial in COVID-19 Pandemics, sponsored by National Taiwan University.

Who is sponsoring NCT05188456?

NCT05188456 is sponsored by National Taiwan University.

What condition does NCT05188456 study?

NCT05188456 studies COVID-19 Pandemics, Human Immunodeficiency Virus.

Is NCT05188456 still recruiting?

NCT05188456 is currently status unknown. Last updated 24 April 2023.

Last reviewed 2023-04-24 · How we verify

NCT05188456

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Impact Evaluation of the COVID-19 Prevention on Risk Factors of HIV and Sexually Transmitted Comorbidity

Status unknown Last updated 24 April 2023

What this trial tests

trial in COVID-19 Pandemics in 2,200 participants. Status unknown.

Timeline

13 January 2022

Primary endpoint
30 June 2023

31 July 2023

Quick facts

Lead sponsor	National Taiwan University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	2,200
Start date	13 January 2022
Primary completion	30 June 2023
Estimated completion	31 July 2023
Sites	1 location across Taiwan

Conditions studied

COVID-19 Pandemics — all drugs for COVID-19 Pandemics →
Human Immunodeficiency Virus — all drugs for Human Immunodeficiency Virus →

Sponsor

National Taiwan University

Who can join

18 and older, any sex, with COVID-19 Pandemics or Human Immunodeficiency Virus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a cross-sectional research. The Protection Motivation Theory (PMT) was applied as theoretical framework to analyze correlation of prevention knowledge, prevention intentions and anxiety, and prevention behavior of COVID-19 and HIV risk feature and behavior and stigma of people living with HIV/AIDS (PLWHA), and HIV high-risk groups. Purposive and snowball sampling will be applied to recruit participant who visit hospital, HIV/AIDS related institutions, and social media platforms. The investigators expect that the outcome could reveal the relationship of cognition and attitude of COVID-19 to HIV prevention and treatment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other National Taiwan University trials

Trials by the same sponsor.

NCT07157917 — Thirst Translation and RCT · NA · enrolling by invitation
NCT06913088 — Ultrasonication-mediated Microbubbles Dressing for Hand Arthritis · NA · recruiting
NCT06205147 — Effects of Elastic Band Resistance Exercise on Muscle Strength and Depression in Hospitalized Elderly. · NA · recruiting
NCT07159399 — A Pharmacist-Led Education Program to Improve Adherence to Direct Oral Anticoagulants in Patients With Atrial Fibrillati · NA · enrolling by invitation
NCT06814678 — Interactive Exergaming With Otago Exercise Program on Mobility in Community-Dwelling Older Adults · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05188456 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National Taiwan University
Last refreshed: 24 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05188456.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing